BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9422326)

  • 1. Lymphoblastic lymphoma expressing CD56 and TdT.
    Nakamura S; Koshikawa T; Yatabe Y; Suchi T
    Am J Surg Pathol; 1998 Jan; 22(1):135-7. PubMed ID: 9422326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
    Terada T
    Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [B/T-cell biphenotypic lymphoblastic lymphoma/leukemia: report of a case].
    Chen DB; Wang Y; Dai L
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):704-5. PubMed ID: 24433739
    [No Abstract]   [Full Text] [Related]  

  • 5. CD4+/CD56+ TdT+ haematodermic neoplasm (previously called blastic natural killer cell lymphoma) in a patient with chronic human T-cell leukaemia virus type 1 infection: a previously unreported association.
    Gurgen J; Hogan D; Muller K; Flowers J; Sexton W
    Br J Dermatol; 2010 Jun; 162(6):1395-7. PubMed ID: 20132205
    [No Abstract]   [Full Text] [Related]  

  • 6. TdT-positive primary cutaneous diffuse large B-cell lymphoma, leg type phenotypically mimicking B-lymphoblastic lymphoma.
    Endo M; Ohtsuka M; Watanabe Y; Igari S; Kikuchi N; Taniguchi K; Yoshino T; Yamamoto T
    J Cutan Pathol; 2021 May; 48(5):721-724. PubMed ID: 33403671
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.
    Buresh CJ; Oliai BR; Miller RT
    Am J Clin Pathol; 2008 Jun; 129(6):894-8. PubMed ID: 18480005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ewing sarcoma vs lymphoblastic lymphoma. A comparative immunohistochemical study.
    Lucas DR; Bentley G; Dan ME; Tabaczka P; Poulik JM; Mott MP
    Am J Clin Pathol; 2001 Jan; 115(1):11-7. PubMed ID: 11190795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Cytoplasmic Terminal Deoxynucleotidyl Transferase (TdT) Immunostaining on Previously Frozen, Formalin-fixed Paraffin-embedded Tissue: Cryotomy-induced Antigen Diffusion (CIAD).
    Henwood AF
    Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):e17-e19. PubMed ID: 32590454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances of lymphoblastic lymphoma and its molecular genetics].
    Pan Y; Li GD; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):236-9. PubMed ID: 16091181
    [No Abstract]   [Full Text] [Related]  

  • 11. Terminal deoxynucleotidyl transferase negative B-lymphoblastic leukaemia/lymphoma with CD138 expression.
    Lee SY; Hue SS
    Pathology; 2020 Feb; 52(2):286-289. PubMed ID: 31883671
    [No Abstract]   [Full Text] [Related]  

  • 12. Pitfall in the use of terminal deoxynucleotidyl transferase (TdT) in the cytological diagnosis of lymphoma.
    Ingoldsby H; Billett P; Leader M
    Histopathology; 2013 Jan; 62(2):359-60. PubMed ID: 23020221
    [No Abstract]   [Full Text] [Related]  

  • 13. Tdt-positive ALL-L3.
    Lenhardt TM; Ganey JT; Hodges GF; Frame JN; Cotelingam JD
    Am J Clin Pathol; 1992 May; 97(5):741-2. PubMed ID: 1374216
    [No Abstract]   [Full Text] [Related]  

  • 14. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
    Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
    J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indolent T-lymphoblastic proliferation: report of a case with an 11-year history and association with myasthenia gravis.
    Strauchen JA
    Am J Surg Pathol; 2001 Mar; 25(3):411-5. PubMed ID: 11224614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningeal relapse in a case of B acute lymphoblastic leukemia: the role of CD56 expression.
    Cannizzo E; Carulli G; Buda G; Zucca A; AzzarĂ  A; Orciuolo E; Petrini M
    Med Sci Monit; 2009 Feb; 15(2):CS27-29. PubMed ID: 19179973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD56 is a risk factor for acute lymphocytic leukemia with central nervous system involvement in adults.
    Hu W; Wang X; Yang R; Bi L; Xie Y; Zhang Z; Lu H; Wu L
    Hematology; 2017 Mar; 22(2):81-87. PubMed ID: 27734763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56-positive acute lymphoblastic leukemia.
    Matano S; Terahata S; Nakamura S; Kobayashi K; Sugimoto T
    Acta Haematol; 2005; 114(3):160-3. PubMed ID: 16227680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of CD56 in acute leukemia and its clinical significance].
    Zhang Y; Tang YM; Yang SL; Shen HQ; Qian BQ; Song H; Shi SW; Xu WQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):187-90. PubMed ID: 12513782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections.
    Orazi A; Cattoretti G; John K; Neiman RS
    Mod Pathol; 1994 Jun; 7(5):582-6. PubMed ID: 7937725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.